Specify a stock or a cryptocurrency in the search bar to get a summary
Clinical Laserthermia Systems AB (publ)
CLS-BClinical Laserthermia Systems AB (publ) engages in the development of treatment tools for diseased tissue under the TRANBERG brand in Sweden. The company offers TRANBERG, a thermal therapy system designed to deliver laser energy to heat the target tissue. It also provides mobile laser unit, a controlling component with a wavelength of 1064 nanometers provides multiple options to control treatment. In addition, the company offers various gauge laser applicators, as well as provides temperature and treatment monitoring devices. Clinical Laserthermia Systems AB (publ) was incorporated in 2006 and is headquartered in Lund, Sweden. Address: Building 405, Lund, Sweden, 223 81
Analytics
WallStreet Target Price
223.67 SEKP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures CLS-B
Dividend Analytics CLS-B
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History CLS-B
Stock Valuation CLS-B
Financials CLS-B
Results | 2019 | Dynamics |